Skip to main content
SpringerLink
Log in
Book cover

Update in Heart Valve Replacement pp 79–86Cite as

Prosthetic Valve-related or Valve-induced Complications

  • Conference paper

  • 45 Accesses

Abstract

All artificial heart valves are associated with a high rate of valve-related (mechanical dysfunction) or valve-induced complications (1,2). The valve-related complications can be direct consequences of hemodynamic disturbances persisting postoperatively (intravascular hemolysis), of the implanted artificial material (mechanical dysfunctions) or of both factors (prosthetic valve endocarditis, thrombosis of the prosthesis, thromboembolic events).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Silver MD (1979) Late complications of prosthetic heart valves: a pathologist’s viewpoint. Am Heart J 88: 668.

    Article  Google Scholar 

  2. Horstkotte D, Körfer R, Seipel L et al (1983) Late complications in patients with Björk-Shiley and St. Jude Medical heart valve replacement. Circulation 68 (Suppl II): 175

    Google Scholar 

  3. Horstkotte D, Rosin H (1984) Therapy and prophylaxis of infective endocarditis. Schw Med Wsch 144: 1575

    Google Scholar 

  4. Gehrmann, G, Bleifeld W, Loogen F (1966) Mechanische Hämolyse nach Implantation künstlicher Herzklappen. Z Kreislaufforschung 55: 25

    CAS  Google Scholar 

  5. Horstkotte D, Aul C, Seipel L et al (1983) Influence of valve type and valve function on chronic intravascular hemolysis following mitral and aortic valve replacement using alloprostheses. Z Kardiol 72: 119

    PubMed  CAS  Google Scholar 

  6. Schistek R, Benzer A, Scharfetter H (1984) Toxic complication after implantation of aortic valves. Life Supp Syst, Proceeding XIth. Ann Meeting ESAO: 63

    Google Scholar 

  7. Crexells C, Aerichide N, Bonny Y et al (1972) Factors influencing hemolysis in valve prostheses. Am Heart J 84: 161

    Article  PubMed  CAS  Google Scholar 

  8. Sallam IA, Show A, Bain WH (1976) Experimental evaluation of mechanical hemolysis with Starr-Edwards, Kay-Shiley, and Björk-Shiley valves. Scand J Thorac Cardiovasc Surg 10: 117

    Google Scholar 

  9. Horstkotte D, Haerten K, Leuner Chr et al (1978) Chronic intravascular hemolysis following mitral valve replacement with Björk-Shiley, Lillehei-Kaster, and Starr-Edwards prostheses Z Kardiol 67: 629

    CAS  Google Scholar 

  10. Gentle CR (1982) Characterisation of leakage flow in cardiac valve prostheses. Life Supp Syst

    Google Scholar 

  11. Proceedings IXth, Ann Meeting ESAO: 102

    Google Scholar 

  12. Bellhouse BJ Bellhouse FH (1976) Fluid mechanic performance of five prosthetic mitral valves. In: Kalmanson D (ed) The mitral valve: A pluridisciplinary approach. Arnold, London p 247

    Google Scholar 

  13. Levang OW, Levorstad K, Honglend T (1980) Aortic valve replacement. A nonrandomized study comparing the Björk-Shiley and Lillehei-Kaster disc valves. Scand J Thorac Cardiovasc Surg 14: 7

    Google Scholar 

  14. Dellsperger KC, Wieting DW, Baehr DA (1983) Regurgitation of prosthetic heart valves: Dependence on heart and cardiac output. Am J Cardiol 51: 321

    Google Scholar 

  15. Richardson JV, Karp RB, Kirklin JW et al (1978) Treatment of infective endocarditis: A 10-year comparative analysis. Circulation 58: 589

    Article  PubMed  CAS  Google Scholar 

  16. Watanakunakorn C (1979) Prosthetic valve endocarditis. Progr Cardiovasc Dis 22: 181

    Article  CAS  Google Scholar 

  17. Dismukes WE (1981) Prosthetic valve endocarditis: Factors influencing outcome and recommendations for therapy. In: Bisno AL (ed) Treatment of infective endocarditis. Grune and Stratton, New York, London, Toronto, p 167

    Google Scholar 

  18. Horstkotte D, Körfer R, Loogen F et al (1984) Prosthetic valve endocarditis: Clinical findings and management. Eur Heart J 5 (Suppl C): 117

    Article  PubMed  Google Scholar 

  19. Johnson WD (1976) Prosthetic valve endocarditis In: Kaye D (ed) Infective Endocarditis. Univ Park Press, Baltimore, p 129

    Google Scholar 

  20. Arnett EN, Kastl DG, Garvin AJ et al (1977) A conversation on prosthetic valve endocarditis. Am Heart J 93: 510

    Article  Google Scholar 

  21. Magilligan DJ, Quinn EL, Davila JC (1977) Bacteremia endocarditis and the Hancock valve. Ann Thor Surg 24: 508

    Article  Google Scholar 

  22. Ferrans VJ, Boyce SW, Billingham ME et al (1979) Infection of glutaraldehyde-preserved porcine valve heterografts. Am J Cardiol 43: 1123

    Article  PubMed  CAS  Google Scholar 

  23. Madison J, Wang K, Gobel FL et al (1975) Prosthetic aortic valvular endocarditis. Circulation 51: 940

    Article  PubMed  CAS  Google Scholar 

  24. Masur H, Johnson WD (1980) Prosthetic valve endocarditis. J Thor Cardiovasc Surg 80: 31

    CAS  Google Scholar 

  25. Karchmer AW, Dismukes WE, Buckley NU (1978) Late prosthetic valve endocarditis: Clinical features influencing therapy. Am J Med 64: 199

    Google Scholar 

  26. Richardson JV, Karp RB, Kirklin JW et al (1978) Treatment of infective endocarditis: A 10 year comparative analysis. Circulation 58: 589

    Article  PubMed  CAS  Google Scholar 

  27. McAnulty JH, Rahimtoola SH (1979) Surgery for infective endocarditis. JAMA 242: 77

    Article  PubMed  CAS  Google Scholar 

  28. Everett ED, Hirshman JV (1977) Transient bacteremia and endocarditis prophylaxis: A review. Medicine 56: 61

    Google Scholar 

  29. Bisno AL (1981) Antimicrobial prophylaxis of infective endocarditis. In: Bisno AL (ed) Treatment of infective endocarditis. Grune and Stratton, New York, p 281

    Google Scholar 

  30. Sugure D, Blake S, Tray P, MacDonald D (1980) Antibiotic prophylaxis against infective endocarditis after normal delivery - is it necessary? Br Heart J 44: 499

    Article  Google Scholar 

  31. Shulman ST, Amren DP, Bisno AL et al (1984) Prevention of bacterial endocarditis. A statement for health professionals by the Committee on rheumatic fever and infective endocarditis of the Council on cardiovascular disease in the young. Circulation 70: 1123

    Google Scholar 

  32. Durack DT, Beeson PB, Petersdorf RG (1973) Experimental bacterial endocarditis III. Production and progression of the disease in rabbits. Br J Exp Pathol 54: 142

    Google Scholar 

  33. Brooks SL (1980) Survey of the compliance with the American Heart Association guidelines for the prevention of bacterial endocarditis. J Am Dent Assoc 101: 41

    PubMed  CAS  Google Scholar 

  34. Hashway T, Stone LJ (1982) Antibiotic prophylaxis of subacute bacterial endocarditis for adult patients by dentists in Dade County, Florida. Circulation 66: 1110

    Google Scholar 

  35. Petersdorf RG (1978) Antimicrobial prophylaxis of bacterial endocarditis. Prudent caution or bacterial overkill? Am J Med 65: 220

    Article  PubMed  CAS  Google Scholar 

  36. Working Party of the British Society for Antimicrobial Chemotherapy (1982) The antibiotic prophylaxis of infective endocarditis. Lancet 1982/II: 1323

    Google Scholar 

  37. Glauser MP, Bernard JP, Moreillon P (1983) Successful single-dose amoxillin prophylaxis against experimental streptococcal endocarditis: Evidence for two mechanisms of protection. J Infect Dis 147: 568

    Google Scholar 

  38. Stein PD, Sabbah HN (1974) Measured turbulence and its effect on thrombus formation. Circulation Res 35: 608

    Article  PubMed  CAS  Google Scholar 

  39. Steele PP, Weily HS, Davies H et al (1975) Platelet survival time following aortic valve replacement. Circulation 551: 358

    Article  Google Scholar 

  40. Rieger H (1976) Zur Physiologie and Pathophysiologie der Blutplättchen unter rheologischen Aspekten. Habil RWTH Aachen

    Google Scholar 

  41. Emery RW, Nicoloff DM (1979) St. Jude Medical cardiac valve prosthesis. In vitro studies. J Thor Cardiovasc Surg 78: 269

    Google Scholar 

  42. Horstkotte D, Haerten K, Herzer JA et al (1981) Preliminary results in mitral valve replacement with the St. Jude Medical prosthesis: Comparison with the Björk-Shiley valve. Circulation 64 (Suppl I): 203

    Google Scholar 

  43. Nunez L, Iglesias A, Stillo J (1980) Entrapment of leaflet of St. Jude Medical cardiac valve prosthesis by miniscule thrombus: Report of two cases. Ann Thorac Surg 29: 567

    Google Scholar 

  44. Cohn LH (1979) Bioprosthetic cardiac valves - anticoagulation or not? In: Sebening F et al (eds) Bioprosthetic cardiac valves. Deutsches Herzzentrum, Munich, p 107

    Google Scholar 

  45. Horstkotte D, Körfer R, Budde Th (1983) Late complications following Björk-Shiley and St. Jude Medical heart valve replacement. Z Kardiol 72: 251

    Google Scholar 

  46. Horstkotte D, Haerten K, Herzer JA (1983) Five-year results after randomized mitral valve replacement with Björk-Shiley, Lillehei-Kaster and Starr-Edwards prostheses. Thor Cardiovasc Surg 31: 206

    Google Scholar 

  47. Krausz Y, Appelbaum A, Halon DA (1977) Thrombosis on Björk-Shiley aortic valve prostheses. Case report and review of literature. Isr J Med Sci 13: 410

    Google Scholar 

  48. Fuster V, Pumphrey CW, McGoon MD et al (1982) Systemic thromboembolisms in mitral and aortic Starr-Edwards prostheses: A 10–19 year follow-up. Circulation 66 (Suppl I): 157

    Google Scholar 

  49. Loogen F, Horstkotte D (1982) Therapy of cardiovascular disease - valvular heart disease. In: Bleifeld W, Mathey D (eds) Therapy of Cardiovascular Disease. Thieme, p 21

    Google Scholar 

  50. Taguchi K, Matsumura H, Washizu T et al (1975) Effect of athrombogenic therapy, especially high dose therapy of dipyridamole, after prosthetic valve replacement. J Cardiovasc Surg 16: 8

    CAS  Google Scholar 

  51. Sullivan MJ, Harken DE, Gorlin R (1971) Pharmacologic control of thromboembolic complications of cardiac valve replacement. New Engl J Med 284: 1391

    Article  PubMed  CAS  Google Scholar 

  52. Dale J (1977) Prevention of arterial thrombosis with acetylsalicylic acid in patients with prosthetic heart valves. Thromb Haemostas 38: 66

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik, Universität Düsseldorf, Moorenstraße 5, 4000, Düsseldorf, Germany

    Dr. Dieter Horstkotte

Authors
  1. Dr. Dieter Horstkotte
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Loogen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medicine B, University of Düsseldorf, Moorenstraße 5, 4000, Düsseldorf, West Germany

    D. Horstkotte  & F. Loogen  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Horstkotte, D., Loogen, F. (1986). Prosthetic Valve-related or Valve-induced Complications. In: Horstkotte, D., Loogen, F. (eds) Update in Heart Valve Replacement. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-662-10713-3_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10713-3_11

  • Publisher Name: Steinkopff, Heidelberg

  • Print ISBN: 978-3-662-10715-7

  • Online ISBN: 978-3-662-10713-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation